A novel targeting drug carrier to deliver chemical bonded and physical entrapped anti-tumor drugs

被引:8
作者
Huang, Ling [1 ,2 ]
Song, Jinchun [3 ]
Chen, Bangyin [2 ]
机构
[1] Wuhan Docan Pharmaceut Co Ltd, Wuhan 430040, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan 430060, Peoples R China
关键词
Targeting; Drug carrier; Entrapped; Anti-tumor drugs; COMBINED DOXORUBICIN; PH; COPOLYMER; MICELLES; CANCER; FOLATE; NANOPARTICLES; CHEMOTHERAPY; PACLITAXEL; PRODRUGS;
D O I
10.1016/j.ijpharm.2014.03.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we demonstrated a novel targeting drug carrier formed by amphiphilic prodrug based mixed micelle. Along with octadecyl chains, chemical bonded Dox moieties were utilized to entrap free drugs (PTX) and simultaneously acted as therapeutic agents. The formulation of CP-Folate/CPN = Dox/PTX showed spherical micellar structure and possessed high drug loading content, which was up to 22.9%. We examined the cell uptaken capacity and the cytotoxicity of mixed micelle by CLSM and MTT assay. The introducing of folate moiety enhanced intracellular accumulation in HeLa cells and co-delivery of Dox and PTX showed stronger anti-tumor activity even compared with free drugs. (C) 2014 Elsevier B. V. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 21 条
[1]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[2]   Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells [J].
Atkinson, SF ;
Bettinger, T ;
Seymour, LW ;
Behr, JP ;
Ward, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :27930-27935
[3]   Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change [J].
Bae, Y ;
Fukushima, S ;
Harada, A ;
Kataoka, K .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (38) :4640-4643
[4]   Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers [J].
Batrakova, Elena V. ;
Kabanov, Alexander V. .
JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) :98-106
[5]   HIV infection, HAART, and endothelial adhesion molecules: current perspectives [J].
Donati, KD ;
Rabagliati, R ;
Iacoviello, L ;
Cauda, R .
LANCET INFECTIOUS DISEASES, 2004, 4 (04) :213-222
[6]  
Gehl J, 1996, ANN ONCOL, V7, P687
[7]   Pharmacokinetics of combined doxorubicin and paclitaxel in mice [J].
Gustafson, DL ;
Merz, AL ;
Long, ME .
CANCER LETTERS, 2005, 220 (02) :161-169
[8]   Part I: Chemotherapy for epithelial ovarian cancer - treatment at first diagnosis [J].
Harries, M ;
Gore, M .
LANCET ONCOLOGY, 2002, 3 (09) :529-536
[9]   Block copolymer micelles for drug delivery: design, characterization and biological significance [J].
Kataoka, K ;
Harada, A ;
Nagasaki, Y .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :113-131
[10]   Polymer-drug conjugates: Progress in polymeric prodrugs [J].
Khandare, Jayant ;
Minko, Tamara .
PROGRESS IN POLYMER SCIENCE, 2006, 31 (04) :359-397